| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/14/2005 | WO2005063992A1 Novel serum type streptococcus mutans and utilization of the same |
| 07/14/2005 | WO2005063979A1 Cell extract for high-functioned cell-free protein synthesis and method of preparing the extract |
| 07/14/2005 | WO2005063978A1 Fraction and antibody comprising guinea pig immunoglobulin e |
| 07/14/2005 | WO2005063820A2 Il-7 fusion proteins |
| 07/14/2005 | WO2005063816A2 Monovalent antibody fragments useful as therapeutics |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063283A1 Vaccine comprising recombinant clpp protein of streptococcus pneumoniae |
| 07/14/2005 | WO2005063264A1 Immunopotentiator and method of enhancing immunological activity with the same |
| 07/14/2005 | WO2005062977A2 Prostate cancer specific internalizing human antibodies |
| 07/14/2005 | WO2005062916A2 Methods for generating multimeric molecules |
| 07/14/2005 | WO2005033274A3 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom |
| 07/14/2005 | WO2005023990A3 Trans-splicing mediated photodynamic therapy |
| 07/14/2005 | WO2005000871A3 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 07/14/2005 | WO2004063024A3 Floral packaging material having prints thereon |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | US20050155112 Insecticidal protein for use as tool in preventing and controlling corn root worm infestation; biological pest control |
| 07/14/2005 | US20050155103 Transgenic plants expressing lepidopteran-active delta-endotoxins |
| 07/14/2005 | US20050155094 Expression vector comprising nucleotide sequences coding human recombination activating protein (RAG-1) gene for use as tool in generating immunodeficient pigs; animal models and immunotherapy |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050154197 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/14/2005 | US20050154192 Anti-il13 receptor alpha1 neutralizing antibody |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153890 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153879 Process for the preparation of a desired erythropoietin glyco-isoform profile |
| 07/14/2005 | US20050153414 Regulator of G-protein signaling (RGS) polypeptide for use as tools in identifying modulators of cell signaling; antitumor agents; mimetics |
| 07/14/2005 | US20050153405 Such as 4-(Indol-3-ylmethyl)-4-hydroxy-2-oxoglutarate from indole pyruvic acid and pyruvic acid (and/or oxaloacetic acid) by aldolase derived from Pseudomonas, Erwinia, Flavobacterium, and/or Xanthomonas |
| 07/14/2005 | US20050153398 Transgenic cell for use as bioreactor in generation of preferential proteins |
| 07/14/2005 | US20050153397 Methods for producing polypeptides in Aspergillus mutant cells |
| 07/14/2005 | US20050153396 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/14/2005 | US20050153394 Targeting construct for use as tool in enhanced transfer gene sequences into cells; bioreactors; improving exogenous gene expression |
| 07/14/2005 | US20050153392 Transgenesis with humanized immunoglobulin loci |
| 07/14/2005 | US20050153391 Polypeptides capable of binding to G protein coupled receptors as well as DNA encoding for such polypeptides; receptor binding assays; drug screening; obesity; prolactin production inhibitors |
| 07/14/2005 | US20050153390 Lyophilized preparation for synthesis of cell-free protein |
| 07/14/2005 | US20050153378 Anti-dioxins monoclonal antibody suitable for assaying dioxins in environment and hybridoma producing the same |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153348 Using membrane protein expression pattern as diagnostic and prognostic tool in detection of breast, colon and lung tissue cell proliferative disorders |
| 07/14/2005 | US20050153335 Expression vector comprising nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatmment of cell proliferative, inflammatory and nervous system disorders |
| 07/14/2005 | US20050153330 Novel DKR polypeptides |
| 07/14/2005 | US20050153303 Method of mutagenic chain reaction |
| 07/14/2005 | US20050153057 Lipopolysaccharide for influenza vaccines and respiratory system disorders |
| 07/14/2005 | US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 07/14/2005 | US20050152917 Fusion protein for use in the treatment of viral diseases |
| 07/14/2005 | US20050152916 Antigen presenting system and methods for activation of T-cells |
| 07/14/2005 | US20050152904 Novel P-selectin glycoprotein ligand (PSGL-1) binding protein and uses therefor |
| 07/14/2005 | US20050152897 Methods for inducing T cell tolerance to a tissue or organ graft |
| 07/14/2005 | US20050152874 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells |
| 07/14/2005 | US20050152873 Containing an immunogen, a first adjuvant functioning as a directing molecule and a second adjuvant functioning as a stimulant which are chemically distinct |
| 07/14/2005 | DE10315376B4 Verfahren zur Kultivierung des Nitrilhydratase-produzierenden Stammes RHODOCOCCUS RHODOCHROUS M33 Method for the cultivation of the nitrile hydratase producing strain RHODOCOCCUS rhodochrous M33 |
| 07/14/2005 | CA2551915A1 Il-7 fusion proteins |
| 07/14/2005 | CA2551696A1 Immunopotentiator and method of enhancing immunoactivity using the same |
| 07/14/2005 | CA2551008A1 Anti-cd40 antibody mutants |
| 07/14/2005 | CA2550996A1 Methods for generating multimeric molecules |
| 07/14/2005 | CA2550651A1 Novel anti-il 13 antibodies and uses thereof |
| 07/14/2005 | CA2548757A1 Monovalent antibody fragments useful as therapeutics |
| 07/13/2005 | EP1553190A2 Mutations in and genomic structure of HERG - a long QT syndrome gene |
| 07/13/2005 | EP1553184A1 Process for producing tripeptide or higher peptide |
| 07/13/2005 | EP1553182A2 Regulated genes and uses thereof |
| 07/13/2005 | EP1553171A1 Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 07/13/2005 | EP1553168A2 Methods for selectively stimulating proliferation of T cells |
| 07/13/2005 | EP1551988A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 07/13/2005 | EP1551987A1 Protein modification |
| 07/13/2005 | EP1551985A2 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 07/13/2005 | EP1551976A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 07/13/2005 | EP1551952A1 Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter |
| 07/13/2005 | EP1551877A2 Taci antibodies and uses thereof |
| 07/13/2005 | EP1551875A2 Buffered formulations for concentrating antibodies and methods of use thereof |
| 07/13/2005 | EP1551872A2 G-protein coupled receptors |
| 07/13/2005 | EP1551453A2 Specificity grafting of a murine antibody onto a human framework |
| 07/13/2005 | EP1551451A2 Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry |
| 07/13/2005 | EP1551439A2 Improved systems and methods for analysis of protein post-translational modification |
| 07/13/2005 | EP1551435A2 Method for enzymatic production of glp-1 (7-36) amide peptides |
| 07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/13/2005 | EP1551291A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes |
| 07/13/2005 | EP1451341A4 Eit-6, a polypeptide encoded by an estrogen regulated gene |
| 07/13/2005 | EP0804548B1 Patched genes and their use |
| 07/13/2005 | EP0698099B1 Method for the culture in vitro of different stages of tissue parasites |
| 07/13/2005 | EP0681431B1 Production of human recombinant collagen in the milk of transgenic animals |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN1639358A Multiple virus replicon culture systems |
| 07/13/2005 | CN1639345A LIS promoter for expression of transgenes in floral tissues |
| 07/13/2005 | CN1639342A Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 07/13/2005 | CN1639338A Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 07/13/2005 | CN1639322A Recombinant spores |
| 07/13/2005 | CN1639320A Cold shock inducible expression and production of heterologous polypeptides |
| 07/13/2005 | CN1639195A Selective targeting of tumor vasculature using antibody molecules |
| 07/13/2005 | CN1639194A Antibodies against cancer |
| 07/13/2005 | CN1639193A Antibodies against fibroblast growth factor 23 |
| 07/13/2005 | CN1639192A Anti-human tenascin monoclonal antibody |
| 07/13/2005 | CN1639183A Secretion, transcription and sporulation genes in bacillus clausii |
| 07/13/2005 | CN1638800A Human monoclonal antibodies against CD30 |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1637148A Thallus protein, thallus extract and extracted slag and their prepn and use |
| 07/13/2005 | CN1637145A Method of expressing human apolipoprotein ApoA I inside Pichia yeast cell |
| 07/13/2005 | CN1636594A Angiostatin and use of the same for inhibition of angiogenesis |
| 07/13/2005 | CN1210409C Technological process of extracting rice protein fro distiller's grains |
| 07/13/2005 | CN1210402C Broad-spectrum delta-enotoxins |
| 07/13/2005 | CN1210401C Compound from moraxella catarrhalis |